NCT06953323 2025-08-13
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Phase 1/2 Recruiting
Wigen Biomedicine Technology (Shanghai) Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.